FFCM »

Mirati Therapeutics shares owned by FFCM

Quarter-by-quarter ownership of Mirati Therapeutics shares owned by FFCM from 13F filings

Historical chart of FFCM investment in Mirati Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mirati Therapeutics held by FFCM consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mirati Therapeutics by FFCM

Quarter filed Position value Share count Share price at filing
2022-09-30 $1.5M 22k 69.85
2021-12-31 $863k 5.9k 146.64

More positions owned by FFCM

SPDR S&P Technology Select Sector ETF Etf (XLK)
Health Care Select Sector SPDR ETF Etf (XLV)
Financial Select Sector SPDR ETF Etf (XLF)
SPDR S&P Energy Select Sector ETF Etf (XLE)
Communication Services Select Sector SPDR Fund Etf (XLC)
SPDR Bloomberg Barclays 1-3 Month T-Bill ETF Etf (BIL)
Materials Select Sector SPDR ETF Etf (XLB)
Industrial Select Sector SPDR ETF Etf (XLI)
SPDR S&P Consumer Discretionary Select Sector ETF Etf (XLY)
Consumer Staples Select Sector SPDR ETF Etf (XLP)
Real Estate Select Sector SPDR ETF Etf (XLRE)
Utilities Select Sector SPDR ETF Etf (XLU)
Hello Group CCB (Principal)
Pinduoduo CCB (Principal)
Wayfair CCB (Principal)

View all positions for FFCM

Top funds holding Mirati Therapeutics

EcoR1 Capital
Vanguard Group
venBio Select Advisor
Baker Bros. Advisors
Boxer Capital
Sawtooth Asset Management
Braslyn
Alpine Associates Management
Tang Capital Management
Paradigm Biocapital Advisors
Pentwater Capital Management
CSS
Hsbc Holdings
Norges Bank Investment Management
Alliancebernstein

View all funds holding Mirati Therapeutics